These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 8240341)
1. Membrane-associated N-myristoyltransferase activity is reduced in obese (fa/fa) Zucker rat liver. King MJ; Pugazhenthi S; Khandelwal RL; Sharma RK Biochem Biophys Res Commun; 1993 Oct; 196(2):665-70. PubMed ID: 8240341 [TBL] [Abstract][Full Text] [Related]
2. In vivo modulation of N-myristoyltransferase activity by orthovanadate. King MJ; Pugazhenthi S; Khandelwal RL; Sharma RK Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):151-5. PubMed ID: 8927031 [TBL] [Abstract][Full Text] [Related]
3. Potential role of N-myristoyltransferase in pathogenic conditions. Sharma RK Can J Physiol Pharmacol; 2004 Oct; 82(10):849-59. PubMed ID: 15573145 [TBL] [Abstract][Full Text] [Related]
4. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555. Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762 [TBL] [Abstract][Full Text] [Related]
5. Differential activation of bovine brain N-myristoyltransferase(s) by a cytosolic activator. King MJ; Sharma RK Biochem Biophys Res Commun; 1995 Jul; 212(2):580-8. PubMed ID: 7626073 [TBL] [Abstract][Full Text] [Related]
6. Activity of hepatic glucose phosphorylating and NADPH generating enzymes in Zucker rats. Huupponen R; Karvonen I; Sotaniemi E Diabetes Res; 1989 Mar; 10(3):143-6. PubMed ID: 2680227 [TBL] [Abstract][Full Text] [Related]
7. Modulation of gluconeogenesis by epinephrine in hepatocytes isolated from genetically obese (fa/fa) Zucker rats. Sánchez-Gutiérrez JC; Sánchez-Arias JA; Samper B; Felíu JE Arch Biochem Biophys; 2000 Jan; 373(1):249-54. PubMed ID: 10620345 [TBL] [Abstract][Full Text] [Related]
8. Energy restriction reduces the number of advanced aberrant crypt foci and attenuates the expression of colonic transforming growth factor beta and cyclooxygenase isoforms in Zucker obese (fa/fa) rats. Raju J; Bird RP Cancer Res; 2003 Oct; 63(20):6595-601. PubMed ID: 14583451 [TBL] [Abstract][Full Text] [Related]
9. Merit of physical exercise to reverse the higher gene expression of hepatic phosphoenolpyruvate carboxykinase in obese Zucker rats. Chang SP; Chen YH; Chang WC; Liu IM; Cheng JT Life Sci; 2006 Jun; 79(3):240-6. PubMed ID: 16458327 [TBL] [Abstract][Full Text] [Related]
10. Physiological difference between obese (fa/fa) Zucker rats and lean Zucker rats concerning adiponectin. Oana F; Takeda H; Hayakawa K; Matsuzawa A; Akahane S; Isaji M; Akahane M Metabolism; 2005 Aug; 54(8):995-1001. PubMed ID: 16092047 [TBL] [Abstract][Full Text] [Related]
12. Alleviation of hepatic steatosis accompanied by modulation of plasma and liver TNF-alpha levels by Trigonella foenum graecum (fenugreek) seeds in Zucker obese (fa/fa) rats. Raju J; Bird RP Int J Obes (Lond); 2006 Aug; 30(8):1298-307. PubMed ID: 16477270 [TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor (IGF) gene expression is reduced in neural tissues and liver from rats with non-insulin-dependent diabetes mellitus, and IGF treatment ameliorates diabetic neuropathy. Zhuang HX; Wuarin L; Fei ZJ; Ishii DN J Pharmacol Exp Ther; 1997 Oct; 283(1):366-74. PubMed ID: 9336345 [TBL] [Abstract][Full Text] [Related]
14. Acetyl-CoA carboxylases 1 and 2 show distinct expression patterns in rats and humans and alterations in obesity and diabetes. Kreuz S; Schoelch C; Thomas L; Rist W; Rippmann JF; Neubauer H Diabetes Metab Res Rev; 2009 Sep; 25(6):577-86. PubMed ID: 19618481 [TBL] [Abstract][Full Text] [Related]
15. Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes. Leonard BL; Watson RN; Loomes KM; Phillips AR; Cooper GJ Acta Diabetol; 2005 Dec; 42(4):162-70. PubMed ID: 16382303 [TBL] [Abstract][Full Text] [Related]
16. Dietary conjugated linoleic acid preserves pancreatic function and reduces inflammatory markers in obese, insulin-resistant rats. Noto A; Zahradka P; Ryz NR; Yurkova N; Xie X; Taylor CG Metabolism; 2007 Jan; 56(1):142-51. PubMed ID: 17161237 [TBL] [Abstract][Full Text] [Related]
17. Bone responses to body weight and moderate treadmill exercising in growing male obese (fa/fa) and lean Zucker rats. Ip TY; Peterson J; Byrner R; Tou JC J Musculoskelet Neuronal Interact; 2009; 9(3):155-66. PubMed ID: 19724150 [TBL] [Abstract][Full Text] [Related]
18. Differences in the pharmacokinetics of peroxisome proliferator-activated receptor agonists in genetically obese Zucker and sprague-dawley rats: implications of decreased glucuronidation in obese Zucker rats. Kim MS; Wang S; Shen Z; Kochansky CJ; Strauss JR; Franklin RB; Vincent SH Drug Metab Dispos; 2004 Sep; 32(9):909-14. PubMed ID: 15319330 [TBL] [Abstract][Full Text] [Related]
19. Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat. Broca C; Breil V; Cruciani-Guglielmacci C; Manteghetti M; Rouault C; Derouet M; Rizkalla S; Pau B; Petit P; Ribes G; Ktorza A; Gross R; Reach G; Taouis M Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E463-71. PubMed ID: 15082420 [TBL] [Abstract][Full Text] [Related]